Regulated Information
Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands
Press releases92.87 KB • January, 10th 2024
Termination and implementation of the liquidity contract
Share buy-back programs and liquidity contract58.38 KB • January, 2nd 2024
Appointment of BW Gestão de Investimentos as member of Elis Supervisory Board
Press releases59.85 KB • December, 18th 2023
Disclosure of the number of shares forming the capital and of the number of voting rights as of 30 11 2023
Voting rights61.18 KB • December, 11th 2023
S&P Global Ratings upgrades Elis to an Investment Grade credit BBB- rating
Press releases85.5 KB • November, 17th 2023
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 10 2023
Voting rights326.92 KB • November, 16th 2023
Share capital increase reserved for employees “Elis for All 2023”
Press releases60.46 KB • November, 7th 2023
Disclosure of trading in own shares occurred from October 30 to November 3, 2023
Share buy-back programs and liquidity contract172.63 KB • November, 6th 2023
Acquisition of Compania de Tratamiento Levante
Press releases53.87 KB • November, 2nd 2023
Appointment of Mr. Alexis Martineau as board observer (censeur) of Elis Supervisory Board
Press releases138.72 KB • October, 27th 2023